Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB-ALIP vs NITRAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB-ALIP vs NITRAZEPAM: Safety Overview

Metric NIRSEVIMAB-ALIP NITRAZEPAM
Total FAERS Reports 783 1,165
Deaths Reported 32 365
Death Rate 4.1% 31.3%
Hospitalizations 281 466
Average Patient Age 3.3 yrs 51.2 yrs
% Female Patients 46.3% 54.1%
Marketing Status Prescription N/A